Literature DB >> 3825163

[Successful treatment of autoimmune hemolytic anemia with cyclosporin A].

H Pogglitsch, H Warnkross, V Weinrauch, H M Winkler.   

Abstract

A sixty-year-old patient suffering from an idiopathic immunohemolytic anemia was treated by 3 plasma exchanges (with 31 exchange-volume) and following by Ciclosporin A (3 mg/kg body weight) after the monotherapy of prednisone has been unsuccessful. Ciclosporin A promptly effected a continuous remission of the autoimmune hemolysis. The mode of action of Ciclosporin A in immunhemolytic anemia depending on incomplete warm-auto-antibodies is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3825163

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  3 in total

Review 1.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

Review 2.  Immunotherapy treatments of warm autoimmune hemolytic anemia.

Authors:  Bainan Liu; Wangang Gu
Journal:  Clin Dev Immunol       Date:  2013-09-11

3.  Warm Autoimmune Hemolytic Anemia: Clinical Profile and Management.

Authors:  Sreenivasa Rao Sudulagunta; Monica Kumbhat; Mahesh Babu Sodalagunta; Aravinda Settikere Nataraju; Shiva Kumar Bangalore Raja; Keshava Chandra Thejaswi; Raj Deepak; Asif Hussain Mohammed; Sony P Sunny; Amulya Visweswar; Mikita Suvarna; Rashmi Nanjappa
Journal:  J Hematol       Date:  2017-03-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.